Header Image
Emotionally unstable personality disorder / borderline personality disorder

Emotionally unstable personality disorder / borderline personality disorder

Emotionally unstable personality disorder (colloquially: borderline personality disorder, hereafter abbreviated to borderline or BPD) is a common misdiagnosis in cases of severe ADHD-C or ADHD-HI.
Semmler attributes this to the fact that the most widely used borderline test, the SKID-II interview, as well as its successor, the SKID-5, ask about the dimensions of emotional instability and impulsivity in a joint construct and therefore mix them inappropriately. The SKID interviews are said to cause frequent misdiagnoses as a result. The IKP (Inventory of Clinical Personality Accentuations) separates these two dimensions and can be re-explored with the Borderline Personality Inventory (BPI) in the case of high scores.1

1. Prevalence of borderline BPD

Borderline prevalence: 0.7 % - 2.7 %2, 1 % - 3 %3, 5 %45 In psychiatric patients, the prevalence increases to 11 %6 to 12 %2, in hospitalized patients to 22 %2 to 50 %.6

75% of people with ADHD are women.

2. Borderline with ADHD

ADHD increases the risk of a BPD diagnosis to 33.7%7. More on this at Borderline PS / Emotionally unstable PS In the article Psychiatric comorbidities in ADHD.
However, we are seeing a high number of borderline diagnoses that ultimately turn out to be ADHD, which is fully treatable with stimulants. Given the high symptom similarity and the only slowly developing awareness of how far-reaching symptoms and consequences ADHD can have, this is not surprising in our view.

In the case of borderline, in addition to a symptom similarity to ADHD, a comorbid occurrence of ADHD is often found.289 One study addresses the question of whether one of the disorders (ADHD or borderline) can develop into one of the other disorders over time. Apparently, ADHD is more likely to be a preceding Disorder and Borderline is more likely to be a subsequent Disorder in adulthood. The increased number of traumatic childhood experiences in borderline was reported as a significant difference in environmental influences. This, as well as the different genetic disposition described below, argues against a regular developmental sequence between the two disorders. Nevertheless, we are aware of individual cases in which we consider a development from ADHD to a later borderline or a later addition of borderline to be a plausible explanation for the symptom pattern.10

Since borderline is associated with a genetic disposition on the MAO-A gene, which is also associated with aggression and behavioral disorders, borderline is likely to co-occur primarily with ADHD-HI and barely with ADHD-I.
ADHD resembles a personality disorder in its course (early onset, persistent behavior patterns and possible continuation into adulthood).11
There are those who view ADHD-HI (with hyperactivity) and borderline as a continuum that varies in symptom intensity. One study found that ADHD and borderline are less distinguishable on the basis of individual symptoms, but differ primarily in the intensity of borderline symptoms.12 Hallowell reports an ADHD-HI type with borderline overtones.13 We also see a conspicuous relationship, to the point of strong confusability for laypersons, but assume that the aggressiveness associated with borderline is mediated by genes that are not typical for ADHD. As the correlating gene variants show, ADHD is characterized by a deficit of dopamine and noradrenaline in the dlPFC and striatum, while borderline is characterized by a normal dopamine level in the PFC and an excess of dopamine in the striatum (see below).

3. Differential diagnosis of borderline and ADHD

Borderline and ADHD have very similar symptoms, which are easily confused, and a high level of comorbidity. Around 50% of people with ADHD also suffer from borderline ADHD.
The “inner pressure” described in borderline (which can lead to self-harming behavior) is also known in ADHD.

Many adult women with borderline report increased ADHD symptoms in childhood,14

Differentiation of the symptoms of ADHD and borderline:15

The previous assumption that ADHD and borderline differ in the time of onset (ADHD earlier, borderline later) is now being questioned.9

The BPFSC-11 appears to be good at differentiating borderline and ADHD.16

3.1. Common symptoms of borderline and ADHD

  • Impulsiveness1718 19 20
    • Significantly stronger in ADHD-HI/ADHD-C than in Borderline
    • High impulsivity in borderline is thought to indicate ADHD-HI comorbidity.
    • Other view: high aggressive impulsivity an endophenotype of BPD.21 We think this is more likely because DAT 9R, the gene suspected in borderline for aggressive-impulsive behavior, is not associated with ADHD. (see below).
    • One study found increased self-reported impulsivity in ADHD and borderline, but increased action impulsivity only in ADHD22
    • Borderline: Impulsivity only in relation to negative affects, ADHD: Impulsivity also in relation to positive affects23
    • Borderline: Impulsivity only under stress; ADHD: independent of stress24
    • Addiction problems18
  • Affective lability (ADHD-HI) / affective instability (borderline)18
    • In persons with ADHD-HI (with hyperactivity) and borderline people with ADHD, behavior and affect regulation are similarly disturbed.
    • Rapid mood swings17
    • Emotional dysregulation is even more pronounced in borderline than in ADHD. People with ADHD have a better use of adaptive cognitive emotional strategies than borderline sufferers.25 All emotions are perceived considerably more intensely (and with more stressful intensity) than in non-affected persons.5
    • Borderline behavioral dysregulation also does not occur in neutral life circumstances, but only in stressful moments.19
    • Mood swings:
      • Borderline: Anger and aggression, often caused by interactional triggers.26
      • ADHD: can become angry quickly. Anger is almost always short-lived and not regularly directed at interactional triggers. However, the affect can also tip over into hypomania.26
  • Attention deficit disorders
    • In ADHD often with too little arousal (lack of activation / stimulation)18
    • More frequent in BPD with voltage increase as a dissociative phenomenon11
    • Borderline: no attention problems with boring things, ADHD: attention problems especially with boring things23
  • Dissatisfaction
  • Dysphoria with inactivity
  • Boredom (ADHD-HI) / Dysphoria, boredom, emptiness (borderline)
  • Self-esteem issues / offendedness / rejection sensitivity18
  • Excitability, outbursts of anger
  • Stress intolerance
    • Stressors lead to considerably higher stress levels in borderline patients, which decrease much more slowly than in those not affected.5
  • Conflictual relationships (ADHD-HI) / instability in relationships (borderline)18
  • Social weakness, impaired social behavior
  • Sleep problems common
    • Borderline often shows a prolonged REM phase and nightmares (on average every 2nd night).27 Nightmares are atypical for ADHD.
    • Difficulty falling asleep, shortened sleep duration, low sleep efficiency with subjectively less restful sleep are common in Borderline,27 as well as in ADHD.
    • Difficulty falling asleep in borderline patients is said to improve well with clonidine.27 Guanfacine could probably also be helpful.
  • Inner restlessness, restlessness17
    • Required voltage reduction
      • For ADHD-HI (more often men): sports, sex18
      • In BPD (more often women): Dissociation, freezing, self-harm,18 sex
  • Risk behavior
    • BPD: Inner motive: coming out of numbness or self-punishment26
    • ADHD: Inner motive: having fun or relaxation through overstimulation26

3.2. ADHD symptoms that are atypical for Borderline:

  • Concentration problems1724
  • Attention problems1724
    • Attention problems with boring things23
  • Distractibility24
  • Hyperfocus24
  • Motivation problems24
  • Cognitive impairments22
  • Hyperactivity24
  • Dysphoria with inactivity
  • High flow of speech (logorrhea, polyphrasia)17
  • Chasing thoughts, circling thoughts17
  • Disorders of executive functions
    • Disorganization24
  • One study found increased self-reported impulsivity in ADHD and borderline, but increased action impulsivity only in ADHD22
  • Slowing of reaction time28 although other studies have also found shorter reaction times in ADHD

3.3. Symptoms of Borderline that are atypical for ADHD:

  • Self-harming / self-injurious behavior
    Impulsive behavior in response to intense negative feelings (“negative urgency”)22 is one of the most distinctive symptoms that characterize Borderline29
    • E.g. scratching (however, not all self-harming behavior is borderline)
      • Self-injury reduces the very high subjective stress load and objective amygdala activity (by increasing connectivity in frontal-limbic brain regions that dampen amygdala activity) in persons with ADHD after a stress test, while it further increases the (lower) stress load and objective amygdala activity in non-affected persons.5
      • Self-injuries that are unintentional or serve more as self-stimulation therefore do not point to borderline, but rather to ADHD
    • Differentiating here: Blay et al.30
  • Thinking black and white
    • Shades of gray, both-and, mediating positions are difficult to perceive and hard to bear.
    • In discussions, people with ADHD tend to take extreme positions. For the person with ADHD, this can feel as if they are always slipping off a bar of soap, either falling into one extreme or the other, but not being able to take a middle, both/and or mediating position.
  • Identity disorders
  • Dissociation
  • Unstable self-image17
  • Fear of abandonment1724
    • Feeling lonely, even when among people.5 We suspect that this is much more pronounced in borderline than the feeling of not belonging in ADHD
  • Unstable relationships1724
    • Exaggeration at the beginning24
    • Devaluation at the end24
    • Fear of closeness and fear of abandonment26
    • Often paranoid cognitions at an older age26
    • Often resentful.26
  • Suicidal thoughts17
  • Paranoid symptoms17
  • Strong sense of guilt and shame
  • Pervasive feeling of inner emptiness24

Comorbid ADHD + Borderline in particular are said to be more pronounced:9

  • Impulsivity (than with ADHD alone)
  • Symptoms of regulation of traits and emotions (as in borderline alone)

In children and adolescents, certain character traits increase the risk of a later borderline personality disorder:6

  • Affective instability
  • Negative affectivity
  • Negative emotionality
  • Inappropriate anger
  • Poor emotional control
  • Impulsiveness
  • Aggression

People with ADHD differ from those with other personality disorders primarily in their pronounced histrionic and more frequent narcissistic, bipolar/cyclothymic or aggressive characteristics. There is greater instability in relation to anger and anxiety and a greater oscillation in occurrence between depression and anxiety. Surprisingly, the level of intensity of emotion perception is not higher. Obsessive-compulsive, schizoid and anxious-avoidant manifestations, on the other hand, are rarer. These results are independent of gender.31

The use of stimulants in borderline personality disorder is controversial.

  • On the other hand:
    • Dopaminergic substances (stimulants) can provoke impulsive and aggressive behavior in borderline patients.21 This indicates an excess of dopamine in borderline, which differs from the dopamine deficit in ADHD.
      This is consistent with the results of studies according to which borderline correlates with the DAT1 gene variants 9/9 and 9/10, which cause lower DAT expression in the striatum, so that a higher dopamine level in the striatum can be expected due to the lower dopamine degradation caused by DAT.32
  • For this:
    • ADHD treatment with stimulants is also possible in cases of comorbid borderline23
    • MPH can improve impulsivity in pure borderline (without ADHD)33

It should be considered that stimulants can reduce impulsivity, hyperactivity and attention problems in the DAT-KO mouse as well as in several other animal models with ADHD symptoms characterized by excessive extracellular dopamine. More on this at ADHD animal models with elevated extracellular dopamine

The 9-repeat variant of the DAT1 gene causes an excess of dopamine in the synaptic cleft because the dopamine transporters then only reabsorb the dopamine insufficiently presynaptically. DAT 9R is associated with affective disorders and borderline personality disorder.34
Borderline correlated more frequently with32

  • DAT1 9/9 (OR = 2.67)
  • DAT1 9/10 (OR = 3.67)
  • HTR1A G/G (OR = 2.03)

The risk of borderline increases for carriers of the gene variant combinations32

  • DAT1 9/10 and HTR1A G/G (OR = 6.64)
  • DAT1 9/9 and HTR1A C/G (OR = 5.42).

ADHD is not associated with DAT1 9R, but with DAT1 10/10, which causes increased DAT expression in the striatum, which is associated with increased dopamine efflux and therefore decreased dopamine levels in the striatum. This now explains why stimulants that increase dopamine and noradrenaline levels in the PFC and striatum work well in ADHD, while they can be counterproductive in borderline.

In contrast, a review reports that DAT1 9R is associated with childhood ADHD and DAT1 10R with adult ADHD35 and that DAT1 9R correlates with increased DAT activity in healthy individuals (meta-analysis, k = 12, n = 511)36.

5 HTTPLR and 5-HT2c are two other candit data genes in Borderline.37

People with ADHD may have more regional μ-opioid receptors in some brain regions and fewer regional μ-opioid receptors in other brain regions. Emotional dysregulation (sadness) is said to correlate with the deviation of μ-opioid receptors compared to non-affected people.38

In BPD, antipsychotics bring about significant but small improvements in cognitive symptoms, mood instability and global functions. The effect on anger/rage is more pronounced. They have no significant effect on behavioral impulsivity, depression and anxiety.39

A study of n = 17,532 patients with BPD found with different forms of treatment:40

  • the risk of psychiatric rehospitalization
    • increased by
      • Benzodiazepines (HR = 1.38)
      • Antipsychotics (HR = 1.19)
      • Antidepressants (HR = 1.18)
    • unchanged by
      • Mood stabilizers
    • reduced by
      • ADHD medication (HR = 0.88)
      • Clozapine (HR = 0.54)
      • Lisdexamfetamine (HR = 0.79)
      • Bupropion (HR = 0.84)
      • Methylphenidate (HR = 0.90)
  • the risk of hospitalization or death
    • increased by
      • Benzodiazepines (HR = 1.37)
      • Antipsychotics (HR = 1.21)
      • Antidepressants (HR = 1.17)
    • unchanged by
      • Mood stabilizers
    • reduced by
    • ADHD medication (HR = 0.86)

  1. Semmler (2022): ADHS-Diagnostik/Testung Ergebnisse; Differenzialdiagnotik

  2. Leichsenring F, Fonagy P, Heim N, Kernberg OF, Leweke F, Luyten P, Salzer S, Spitzer C, Steinert C (2024): Borderline personality disorder: a comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies. World Psychiatry. 2024 Feb;23(1):4-25. doi: 10.1002/wps.21156. PMID: 38214629; PMCID: PMC10786009. REVIEW

  3. Stone (2011), Entwickelt sich die Borderline-Persönlichkeitsstörung zu einem Massenphänomen?, in: Handbuch der Borderlinestörungen, Seite 60

  4. Habermeyer, Habermeyer, Herpertz (2009): Adulte ADHS und Persönlichkeitsstörungen, S. 166 in: Häßler (Hrsg) (2009): Das ADHS Kaleidoskop – State of the Art und bisher nicht beachtete Aspekte von hoher Relevanz; medizinisch wissenschaftliche Verlagsgesellschaft

  5. Bohus (2016): Mechanisms-Based Psychotherapy: on the Interaction of Psychobiology and Treatment Development

  6. Bozzatello, Bellino, Bosia, Rocca (2019): Early Detection and Outcome in Borderline Personality Disorder. Front Psychiatry. 2019 Oct 9;10:710. doi: 10.3389/fpsyt.2019.00710. eCollection 2019.

  7. Bernardi S, Faraone SV, Cortese S, Kerridge BT, Pallanti S, Wang S, Blanco C (2012): The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Psychol Med. 2012 Apr;42(4):875-87. doi: 10.1017/S003329171100153X. PMID: 21846424; PMCID: PMC3383088. n = 34.000

  8. Winkler, Rossi, Borderline-Persönlichkeitsstörung und Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, Persönlichkeitsstörungen 2001, 5; 39-48

  9. Weiner, Perroud, Weibel (2019): Attention Deficit Hyperactivity Disorder And Borderline Personality Disorder In Adults: A Review Of Their Links And Risks. Neuropsychiatr Dis Treat. 2019 Nov 8;15:3115-3129. doi: 10.2147/NDT.S192871. eCollection 2019.

  10. Calvo, Lara, Serrat, Pérez-Rodríguez, Andión, Ramos-Quiroga, Ferrer (2020): The role of environmental influences in the complex relationship between borderline personality disorder and attention-deficit/hyperactivity disorder: review of recent findings. Borderline Personal Disord Emot Dysregul. 2020 Jan 6;7:2. doi: 10.1186/s40479-019-0118-z. eCollection 2020.

  11. Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, Springer, 2006, Seite 69 mwN

  12. Philipsen A, Feige B, Hesslinger B, Scheel C, Ebert D, Matthies S, Limberger MF, Kleindienst N, Bohus M, Lieb K. (2009): Borderline typical symptoms in adult patients with attention deficit/hyperactivity disorder. Atten Defic Hyperact Disord. 2009 May;1(1):11-8. doi: 10.1007/s12402-009-0001-7. PMID: 21432575.

  13. Hallowell, Ratey (1999): Zwanghaft zerstreut.

  14. Alacha HF, Sharp C, Kujawa A, Babinski DE (2025): Altered Social Processing as a Potential Mechanism of BPD Risk in Girls with ADHD: A Call for Multi-Method Developmental Research. J Psychiatr Brain Sci. 2025;10(1):e250001. doi: 10.20900/jpbs.20250001. Epub 2025 Jan 6. PMID: 39949864; PMCID: PMC11822859.

  15. Lampe, Konrad, Kroener, Fast, Kunert, Herpertz (2007): Psychol Med. 2007 Neuropsychological and behavioural disinhibition in adult ADHD compared to borderline personality disorder; Dec;37(12):1717-29. n = 86 dargestellt nach Habermeyer, Habermeyer, Herpertz (2009): Adulte ADHS und Persönlichkeitsstörungen, S. 166 in: Häßler (Hrsg) (2009): Das ADHS Kaleidoskop – State of the Art und bisher nicht beachtete Aspekte von hoher Relevanz; medizinisch wissenschaftliche Verlagsgesellschaft

  16. Calvo N, Marin JL, Vidal R, Sharp C, Duque JD, Ramos-Quiroga JA, Ferrer M (2023): Discrimination of Borderline Personality Disorder (BPD) and Attention-Deficit/Hyperactivity Disorder (ADHD) in adolescents: Spanish version of the Borderline Personality Features Scale for Children-11 Self-Report (BPFSC-11) Preliminary results. Borderline Personal Disord Emot Dysregul. 2023 May 16;10(1):15. doi: 10.1186/s40479-023-00223-2. PMID: 37189168; PMCID: PMC10185374.

  17. Kooij, Huss, Asherson, Akehurst, Beusterien, French, Sasané, Hodgkins (2012): Distinguishing comorbidity and successful management of adult ADHD. J Atten Disord. 2012 Jul;16(5 Suppl):3S-19S. doi: 10.1177/1087054711435361.

  18. Edel, Vollmoeller: Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen, Springer, 2006, Seite 69

  19. Sebastian, Jung, Krause-Utz, Lieb, Schmahl, Tüscher (2014): Frontal Dysfunctions of Impulse Control – A Systematic Review in Borderline Personality Disorder and Attention-Deficit/Hyperactivity Disorder; Front Hum Neurosci. 2014; 8: 698; doi: 10.3389/fnhum.2014.00698; PMCID: PMC4153044

  20. Ditrich, Philipsen, Matthies (2021): Borderline personality disorder (BPD) and attention deficit hyperactivity disorder (ADHD) revisited – a review-update on common grounds and subtle distinctions. Borderline Personal Disord Emot Dysregul. 2021 Jul 6;8(1):22. doi: 10.1186/s40479-021-00162-w. PMID: 34229766; PMCID: PMC8261991. REVIEW

  21. Maier, Hawellek, Genetik, S. 73, in: Dulz, Herpertz, Kernberg, Sachsse (2000/2011): Handbuch der Borderline-Störungen, Schattauer, 2. Auflage

  22. Linhartová, Látalová, Barteček, Širůček, Theiner, Ejova, Hlavatá, Kóša, Jeřábková, Bareš, Kašpárek (2019): Impulsivity in patients with borderline personality disorder: a comprehensive profile compared with healthy people and patients with ADHD. Psychol Med. 2019 Aug 23:1-10. doi: 10.1017/S0033291719001892.

  23. Philipsen, Vortrag 2023

  24. Neff: Borderline Personality Disorder, ADHD, and Autism

  25. Rüfenacht, Euler, Prada, Nicastro, Dieben, Hasler, Pham, Perroud, Weibel (2019): Emotion dysregulation in adults suffering from attention deficit hyperactivity disorder (ADHD), a comparison with borderline personality disorder (BPD). Borderline Personal Disord Emot Dysregul. 2019 Jul 18;6:11. doi: 10.1186/s40479-019-0108-1. eCollection 2019.

  26. Semmler (2022): ADHS-Diagnostik/Testung Ergebnisse; Differenzialdiagnotik: Unterscheidungsheuristiken in der Kontaktgestaltung

  27. Philipsen, Riemann (2011): Schlafstörungen; in: Dulz, Herpertz, Kernberg, Sachsse (2011): Handbuch der Borderline-Störungen

  28. Roshani, Piri, Malek, Michel, Vafaee (2019): Comparison of cognitive flexibility, appropriate risk-taking and reaction time in individuals with and without adult ADHD. Psychiatry Res. 2019 Jul 25:112494. doi: 10.1016/j.psychres.2019.112494.

  29. Peters, Derefinko, Lynam (2017): Negative Urgency Accounts for the Association Between Borderline Personality Features and Intimate Partner Violence in Young Men. J Pers Disord. 2017 Feb;31(1):16-25. doi: 10.1521/pedi_2016_30_234.

  30. Blay M, De Godoy F, Hasler R, Nicastro R, Pham E, Weibel S, Perroud N (2025): Is adult attention deficit hyperactivity disorder associated with non-suicidal self-injury and/or suicidal behaviors? A study on the role of borderline personality disorder comorbidity. J Affect Disord. 2025 May 1;376:313-317. doi: 10.1016/j.jad.2025.02.028. PMID: 39955072.

  31. Koenigsberg, Harvey, Mitropoulou, Schmeidler, New, Goodman, Silverman, Serby, Schopick, Siever (2002): Characterizing Affective Instability in Borderline Personality Disorder; Am J Psychiatry 2002; 159:784–788, n = 152, S. 786 ff

  32. Joyce, Stephenson, Kennedy, Mulder, McHugh (2014): The presence of both serotonin 1A receptor (HTR1A) and dopamine transporter (DAT1) gene variants increase the risk of borderline personality disorder. Front Genet. 2014 Jan 7;4:313. doi: 10.3389/fgene.2013.00313.

  33. Pardossi S, Cuomo A, Koukouna D, Pinzi M, Firenzuoli B, Fagiolini A (2025): Methylphenidate in Borderline Personality Disorder: Assessing Its Therapeutic Potential and Limitations. Life (Basel). 2025 Feb 27;15(3):380. doi: 10.3390/life15030380. PMID: 40141725; PMCID: PMC11944194. REVIEW

  34. Joyce, McHugh, Light, Rowe, Miller, Kennedy (2009): Relationships between angry-impulsive personality traits and genetic polymorphisms of the dopamine transporter; Biol Psychiatry. 2009 Oct 15;66(8):717-21. doi: 10.1016/j.biopsych.2009.03.005.

  35. Faraone, Larsson (2019): Genetics of attention deficit hyperactivity disorder. Mol Psychiatry. 2019 Apr;24(4):562-575. doi: 10.1038/s41380-018-0070-0. PMID: 29892054; PMCID: PMC6477889. REVIEW

  36. Faraone SV, Spencer TJ, Madras BK, Zhang-James Y, Biederman J (2014): Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis. Mol Psychiatry. 2014 Aug;19(8):880-9. doi: 10.1038/mp.2013.126. PMID: 24061496. METASTUDY

  37. Maier, Hawellek, Genetik, S. 74, in: Dulz, Herpertz, Kernberg, Sachsse (2000/2011): Handbuch der Borderline-Störungen, Schattauer, 2. Auflage

  38. Prossin, Love, Koeppe, Zubieta, Silk (2010): Dysregulation of Regional Endogenous Opioid Function in Borderline Personality Disorder; Am J Psychiatry 2010; 167:925–933; geringe Probandenzahl: n = 32

  39. Ingenhoven, Duivenvoorden (2011): Differential Effectiveness of Antipsychotics in Borderline Personality Disorder: Meta-Analyses of Placebo-Controlled, Randomized Clinical Trials on Symptomatic Outcome Domains; Journal of Clinical Psychopharmacology: August 2011 – Volume 31 – Issue 4 – pp 489-496; doi: 10.1097/JCP.0b013e3182217a69; Auswertung von 11 Studien mit n = 1152 Probanden

  40. Lieslehto J, Tiihonen J, Lähteenvuo M, Mittendorfer-Rutz E, Tanskanen A, Taipale H (2023): Association of pharmacological treatments and real-world outcomes in borderline personality disorder. Acta Psychiatr Scand. 2023 Apr 24. doi: 10.1111/acps.13564. Epub ahead of print. PMID: 37094828.

Diese Seite wurde am 24.05.2025 zuletzt aktualisiert.